Use of Nanotechnology in Diagnosis and Treatment of Hepatic Fibrosis: A Review

Current Drug Delivery
Somayeh Taymouri, Azade Taheri

Abstract

Liver fibrosis is an important cause of morbidity and mortality worldwide and represent a difficult clinical challenge of global importance. The liver fibrosis progression needs to be controlled because persisted liver fibrosis can lead to liver cirrhosis or even hepatocellular carcinoma. Despite significant advances in the understanding of the liver fibrosis development, the therapeutic effect of drugs used in liver fibrosis treatment is not sufficient. Today, nanotechnology has been considered as a potential tool for developing novel drug delivery systems for the improved imaging and various diseases, including liver fibrosis. In this article, we discussed the use of nanotechnology for the treatment and imaging of liver fibrosis.

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Journal of Hepatology
L Harivardhan Reddy, Patrick Couvreur
World Journal of Gastroenterology : WJG
Lydia GiannitrapaniMelchiorre Cervello
Indian Journal of Occupational and Environmental Medicine
Kishore P Madhwani
Journal of Controlled Release : Official Journal of the Controlled Release Society
Kinam Park
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
Uday B Kompella
© 2021 Meta ULC. All rights reserved